There is no website visitor data available for this stock.
---
AEZS FAQ
What was Aeterna Zentaris’s price range in the past 12 months?
Aeterna Zentaris lowest stock price was $3.96 and its highest was $12.80 in the past 12 months.
What is Aeterna Zentaris’s market cap?
Currently, no data Available
When is Aeterna Zentaris’s upcoming earnings report date?
Aeterna Zentaris’s upcoming earnings report date is Aug 08, 2024 which is in 36 days.
How were Aeterna Zentaris’s earnings last quarter?
Aeterna Zentaris released its earnings results on May 14, 2024. The company reported -$4.74 earnings per share for the quarter, missing the consensus estimate of N/A by -$4.74.
Aeterna Zentaris does not currently pay dividends.
What is Aeterna Zentaris’s EPS estimate?
Aeterna Zentaris’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aeterna Zentaris have?
Aeterna Zentaris has 3,061,689 shares outstanding.
What happened to Aeterna Zentaris’s price movement after its last earnings report?
Aeterna Zentaris reported an EPS of -$4.74 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.98%.
Which hedge fund is a major shareholder of Aeterna Zentaris?
Currently, no hedge funds are holding shares in AEZS
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.
Copying Boobalan Pachaiyappan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -49.88% per trade.